Umbilical Cord-Derived Cell-Based Interventions for Bronchopulmonary Dysplasia and Related Complications in Preterm Infants: A Bayesian Sparse-Data Meta-Analysis.
Yonghao Wen, Yunlong Duan, Ru Nie et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis evaluated umbilical cord-derived cell-based interventions for bronchopulmonary dysplasia (BPD) in preterm infants. Twelve studies were included, revealing a possible protective effect on overall BPD (OR, 0.48; 95% CrI, 0.14-1.20) and stronger associations for severe BPD (OR, 0.17; 95% CrI, 0.01-0.85) and moderate or severe BPD (OR, 0.28; 95% CrI, 0.09-0.70).
Key findings
- Umbilical cord-derived cell-based interventions showed a possible protective effect on overall BPD (OR, 0.48; 95% CrI, 0.14-1.20).
- Stronger associations were observed for severe BPD (OR, 0.17; 95% CrI, 0.01-0.85).
- Moderate or severe BPD had an odds ratio of 0.28 (95% CrI, 0.09-0.70).
- No treatment-related serious adverse events were identified.
Why it matters
The findings suggest that umbilical cord-derived cell-based interventions may offer a new therapeutic avenue for reducing the incidence and severity of BPD in preterm infants, a condition with significant morbidity.
What to keep in mind
Prediction intervals were generally wide, and the certainty of evidence was low to very low for most outcomes.